Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus
- 275 Downloads
To evaluate the efficacy and safety of trigonella foenum-graecum L. total saponins (TFGs) in combination with sulfonylureas (SU) in the treatment of patients with type 2 diabetes mellitus (T2DM) not well controlled by SU alone.
Sixty-nine T2DM patients whose blood glucose levels were not well controlled by oral sulfonylureas hypoglycemic drug were randomly assigned to the treated group (46 cases) and the control group (23 cases), and were given TFGs or placebo three times per day, 6 pills each time for 12 weeks, respectively. Meanwhile, the patients continued taking their original hypoglycemic drugs. The following indexes, including effects on traditional Chinese medicine (TCM) symptoms, fast blood glucose (FBG), 2-h post-prandial blood glucose (2h PBG), glycosylated hemoglobin (HbA1c), clinical symptomatic quantitative scores (CSQS), body mass index (BMI), as well as hepatic and renal functions, were observed and compared before and after treatment.
The efficacy on TCM symptoms was obviously better in the treated group than that in the control group (P<0.01), and there were statistically remarkable decreases in aspect of FBG, 2h PBG, HbA1c and CSQS in the treated group as compared to those in the control group (P<0.05 or P<0.01), while no signifiClassifi cationcant difference was found in BMI, hepatic and renal functions between the two groups (P>0.05).
The combined therapy of TFGs with sulfonylureas hypoglycemic drug could lower the blood glucose level and ameliorate clinical symptoms in the treatment of T2DM, and the therapy was relatively safe.
Key Wordstrigonella foenum-graecum L. type 2 diabetes mellitus sulfonylureas
Unable to display preview. Download preview PDF.
- 1.Pan CY, Jin WS. Epidemiology of type 2 diabetes mellitus. Chin J Endocrinol Metab (Chin) 2005;21(5):5S1–5S5.Google Scholar
- 2.Xu MY, Lu GH, Chen MD, eds. Diabetes. Shanghai: Shanghai Scientific and Technical Publishers, 2003:304–305.Google Scholar
- 3.Neeraja A, Rajyalakshmi P. Hypoglycemic effect of processed fenugreek seed in humans. J Food Sci Technol 1996;33:427–431.Google Scholar
- 4.The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1057–1058.Google Scholar
- 5.The Special Committee of Diabetes Mellitus, Chinese Association of the Integration of Traditional and Western Medicine. Standard for Diagnosis and Therapeutic Effect Evaluation of Diabetes Mellitus by Integrative Chinese and Western Medicine (Draft, Chin). Chin J Integr Med 2005;25(1):94–95.Google Scholar
- 6.Ministry of Health, P. R. China. Guiding Principle of Clinical Research on New Drugs of TCM. Vol 1. Beijing: People’s Medical Publishing House, 1993:215–217.Google Scholar
- 9.Li LL, Zhang YM, Wang XF, et al. The study of TFGs extracts on type 2 diabetes mellitus mice and rats. J Xinjiang Med Univ (Chin) 2005;28(2):98–101.Google Scholar